Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats

Neuroscience

Volumn 155, Issue 3, 2008, Pages 626-639

  Kumaran, D ^a   Udayabanu, M ^a   Kumar, M ^a   Aneja, R ^b   Katyal, A ^a  

^a UNIVERSITY OF DELHI   (India)

^b Department of Cell Biology   (United States)

Author keywords

angiotensin II; anterograde memory; captopril; Morris water maze; passive avoidance step through task; vascular dementia

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CAPTOPRIL; CHOLINE ACETYLTRANSFERASE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MUSCARINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; BRAIN PERFUSION; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; MAZE TEST; MEMORY; MEMORY DISORDER; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; TASK PERFORMANCE;

ACETYLCHOLINE; AMNESIA, ANTEROGRADE; ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CAPTOPRIL; CHOLINESTERASES; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; INFARCTION, MIDDLE CEREBRAL ARTERY; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MAZE LEARNING; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; TIME FACTORS;

EID: 49249120035     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.06.023     Document Type: Article

References (72)

1. Ando H., Zhou J., Macova M., Imboden H., and Saavedra J.M. Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats. Stroke 35 (2004) 1726-1731
2. Arregui A., Perry E.K., Rossor M., and Tomlinson B.E. Angiotensin converting enzyme in Alzheimer's disease increased activity in caudate nucleus and cortical areas. J Neurochem 38 (1982) 1490-1492
3. Barnes J.M., Barnes N.M., Costall B., Coughlan J., Kelly M.E., Naylor R.J., Tomkins D.M., and Williams T.J. Angiotensin-converting enzyme inhibition, angiotensin and cognition. J Cardiovasc Pharmacol 19 (1992) S63-S71
4. Barnes J.M., Barnes N.M., Costall B., Horovitz Z.P., Ironside J.W., Naylor R.J., and Williams T.J. Angiotensin II inhibits cortical cholinergic function: implications for cognition. J Cardiovasc Pharmacol 16 (1990) 234-238
5. Barnes J.M., Barnes N.M., Costall B., Horovitz Z.P., Ironside J.W., Naylor R.J., and Williams T.J. Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition. Brain Res 507 (1990) 341-343
6. Barnes N.M., Champaneria S., Costall B., Kelly M.E., Murphy D.A., and Naylor R.J. Cognitive enhancing actions of DuP 753 detected in a mouse habituation paradigm. Neuroreport 1 (1990) 239-242
7. Barnes N.M., Cheng C.H., Costall B., Naylor R.J., Williams T.J., and Wischik C.M. Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease. Eur J Pharmacol 200 (1991) 289-292
8. Barnes J.M., Barnes N.M., Costall B., Horovitz Z.P., and Naylor R.J. Angiotensin II inhibits the release of [3H]acetylcholine from rat entorhinal cortex in vitro. Brain Res 491 (1989) 136-143
9. Basso N., Paglia N., Stella I., de Cavanagh E.M., Ferder L., del Rosario Lores Arnaiz M., and Inserra F. Protective effect of the inhibition of the renin-angiotensin system on aging. Regul Pept 128 (2005) 247-252
10. Breteler M.M. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging 21 (2000) 153-160
11. Cook D., and Kesner R.P. Caudate nucleus and memory for egocentric localization. Behav Neural Biol 49 (1988) 332-343
12. Costall B., Coughlan J., Horovitz Z.P., Kelly M.E., Naylor R.J., and Tomkins D.M. The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition. Pharmacol Biochem Behav 33 (1989) 573-579
13. Danielyan L., Lourhmati A., Verleysdonk S., Kabisch D., Proksch B., Thiess U., Umbreen S., Schmidt B., and Gleiter C.H. Angiotensin receptor type 1 blockade in astroglia decreases hypoxia-induced cell damage and TNF alpha release. Neurochem Res 32 (2007) 1489-1498
14. de la Torre J.C. Alzheimer's disease is a vasocognopathy: a new term to describe its nature. Neurol Res 26 (2004) 517-524
15. Dennes R.P., and Barnes J.C. Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze. Psychopharmacology (Berl) 111 (1993) 435-441
16. Denny J.B., Polan-Curtain J., Wayner M.J., and Armstrong D.L. Angiotensin II blocks hippocampal long-term potentiation. Brain Res 567 (1991) 321-324
17. Eckman E.A., Adams S.K., Troendle F.J., Stodola B.A., Kahn M.A., Fauq A.H., Xiao H.D., Bernstein K.E., and Eckman C.B. Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme. J Biol Chem 281 (2006) 30471-30478
18. Egashira T., Takayama F., and Yamanaka Y. Effects of bifemelane on muscarinic receptors and choline acetyltransferase in the brains of aged rats following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries. Jpn J Pharmacol 72 (1996) 57-65
19. Ellman G.L., Courtney K.D., Andres V., and Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7 (1961) 88-95
20. Everitt B.J., and Robbins T.W. Central cholinergic systems and cognition. Annu Rev Psychol 48 (1997) 649-684
21. Farkas E., Luiten P.G., and Bari F. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev 54 (2007) 162-180
22. Flynn D.D., Weinstein D.A., and Mash D.C. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies. Ann Neurol 29 (1991) 256-262
23. Gard P.R. The role of angiotensin II in cognition and behaviour. Eur J Pharmacol 438 (2002) 1-14
24. Gard P.R., and Rusted J.M. Angiotensin and Alzheimer's disease: therapeutic prospects. Expert Rev Neurother 4 (2004) 87-96
25. Giacobini E. Cholinergic receptors in human brain: effects of aging and Alzheimer disease. J Neurosci Res 27 (1990) 548-560
26. Glowinski J., and Iversen L.L. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem 13 (1966) 655-669
27. Groth W., Blume A., Gohlke P., Unger T., and Culman J. Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats. J Hypertens 21 (2003) 2175-2182
28. Grutzendler J., and Morris J.C. Cholinesterase inhibitors for Alzheimer's disease. Drugs 61 (2001) 41-52
29. He M., Ohrui T., Maruyama M., Tomita N., Nakayama K., Higuchi M., Furukawa K., and Arai H. ACE activity in CSF of patients with mild cognitive impairment and Alzheimer disease. Neurology 67 (2006) 1309-1310
30. Hemming M.L., Selkoe D.J., and Farris W. Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease. Neurobiol Dis 26 (2007) 273-281
31. Hu J., Igarashi A., Kamata M., and Nakagawa H. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem 276 (2001) 47863-47868
32. Humpel C., and Marksteiner J. Cerebrovascular damage as a cause for Alzheimer's disease. Curr Neurovasc Res 2 (2005) 341-347
33. Jenkins T.A., and Chai S.Y. Effect of chronic angiotensin converting enzyme inhibition on spatial memory and anxiety-like behaviours in rats. Neurobiol Learn Mem 87 (2007) 218-224
34. Kehoe P.G., and Wilcock G.K. Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?. Lancet Neurol 6 (2007) 373-378
35. Koller M., Krause H.P., Hoffmeister F., and Ganten D. Endogenous brain angiotensin II disrupts passive avoidance behavior in rats. Neurosci Lett 14 (1979) 71-75
36. Kondo Y., Ogawa N., Asanuma M., Matsuura K., Nishibayashi K., and Iwata E. Preventive effects of bifemelane hydrochloride on decreased levels of muscarinic acetylcholine receptor and its mRNA in a rat model of chronic cerebral hypoperfusion. Neurosci Res 24 (1996) 409-414
37. Kudo T., Tada K., Takeda M., and Nishimura T. Learning impairment and microtubule-associated protein 2 decrease in gerbils under chronic cerebral hypoperfusion. Stroke 21 (1990) 1205-1209
38. Kumaran D., Udayabanu M., Unnikrishnan N.R., Ritu A., and Katyal A. Benzamide protects delayed neuronal death and behavioral impairment in a mouse model of global cerebral ischemia. Behav Brain Res 192 (2008) 178-184
39. Lee E.H., Ma Y.L., Wayner M.J., and Armstrong D.L. Impaired retention by angiotensin II mediated by the AT1 receptor. Peptides 16 (1995) 1069-1071
40. Lenkei Z., Palkovits M., Corvol P., and Llorens-Cortes C. Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol 18 (1997) 383-439
41. Liu C., Wu J., Gu J., Xiong Z., Wang F., Wang J., Wang W., and Chen J. Baicalein improves cognitive deficits induced by chronic cerebral hypoperfusion in rats. Pharmacol Biochem Behav 86 (2007) 423-430
42. Lucas S.M., Rothwell N.J., and Gibson R.M. The role of inflammation in CNS injury and disease. Br J Pharmacol 147 (2006) S232-S240
43. Marcus D.L., Thomas C., Rodriguez C., Simberkoff K., Tsai J.S., Strafaci J.A., and Freedman M.L. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 150 (1998) 40-44
44. McKinley M.J., Albiston A.L., Allen A.M., Mathai M.L., May C.N., McAllen R.M., Oldfield B.J., Mendelsohn F.A., and Chai S.Y. The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 35 (2003) 901-918
45. Murakami Y., Ikenoya M., Matsumoto K., Li H., and Watanabe H. Ameliorative effect of tacrine on spatial memory deficit in chronic two-vessel occluded rats is reversible and mediated by muscarinic M1 receptor stimulation. Behav Brain Res 109 (2000) 83-90
46. Murakami Y., Tanaka E., Sakai Y., Matsumoto K., Li H.B., and Watanabe H. Tacrine improves working memory deficit caused by permanent occlusion of bilateral common carotid arteries in rats. Jpn J Pharmacol 75 (1997) 443-446
47. Nanri M., Miyake H., Murakami Y., Matsumoto K., and Watanabe H. GTS-21, a nicotinic agonist, attenuates multiple infarctions and cognitive deficit caused by permanent occlusion of bilateral common carotid arteries in rats. Jpn J Pharmacol 78 (1998) 463-469
48. Ni J., Ohta H., Matsumoto K., and Watanabe H. Progressive cognitive impairment following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries in rats. Brain Res 653 (1994) 231-236
49. Ni J.W., Matsumoto K., Li H.B., Murakami Y., and Watanabe H. Neuronal damage and decrease of central acetylcholine level following permanent occlusion of bilateral common carotid arteries in rat. Brain Res 673 (1995) 290-296
50. Nishimura Y., Ito T., and Saavedra J.M. Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 31 (2000) 2478-2486
51. Oba R., Igarashi A., Kamata M., Nagata K., Takano S., and Nakagawa H. The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide. Eur J Neurosci 21 (2005) 733-740
52. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95 (1979) 351-358
53. Ohrui T., Tomita N., Sato-Nakagawa T., Matsui T., Maruyama M., Niwa K., Arai H., and Sasaki H. Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression. Neurology 63 (2004) 1324-1325
54. Ohrui T., Matsui T., Yamaya M., Arai H., Ebihara S., Maruyama M., and Sasaki H. Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan. J Am Geriatr Soc 52 (2004) 649-650
55. Ouchi Y., Tsukada H., Kakiuchi T., Nishiyama S., and Futatsubashi M. Changes in cerebral blood flow and postsynaptic muscarinic cholinergic activity in rats with bilateral carotid artery ligation. J Nucl Med 39 (1998) 198-202
56. Peng Y., Xu S., Chen G., Wang L., Feng Y., and Wang X. l-3-n-Butylphthalide improves cognitive impairment induced by chronic cerebral hypoperfusion in rats. J Pharmacol Exp Ther 321 (2007) 902-910
57. Raghavendra V., Chopra K., and Kulkarni S.K. Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory. Neuropeptides 32 (1998) 417-421
58. Raghavendra V., Chopra K., and Kulkarni S.K. Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm. Neuropeptides 35 (2001) 65-69
59. Saavedra J.M., Benicky J., and Zhou J. Mechanisms of the anti-ischemic effect of angiotensin II AT(1) receptor antagonists in the brain. Cell Mol Neurobiol 26 (2006) 1099-1111
60. Sarti C., Pantoni L., Bartolini L., and Inzitari D. Persistent impairment of gait performances and working memory after bilateral common carotid artery occlusion in the adult Wistar rat. Behav Brain Res 136 (2002) 13-20
61. Savaskan E. The role of the brain renin-angiotensin system in neurodegenerative disorders. Curr Alzheimer Res 2 (2005) 29-35
62. Savaskan E., Hock C., Olivieri G., Bruttel S., Rosenberg C., Hulette C., and Muller-Spahn F. Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia. Neurobiol Aging 22 (2001) 541-546
63. Schulz R., and Heusch G. Angiotensin II type 1 receptors in cerebral ischaemia-reperfusion: initiation of inflammation. J Hypertens Suppl 24 (2006) S123-S129
64. Semplicini A., Maresca A., Sartori M., Calo L., and Pessina A.C. Hypertension and cerebrovascular diseases: a specific role of vascular protection for the prevention of dementia. J Cardiovasc Pharmacol 38 (2001) S79-S82
65. Skoog I. A review on blood pressure and ischaemic white matter lesions. Dement Geriatr Cogn Disord 9 (1998) 13-19
66. Srinivasan J., Jayadev S., Kumaran D., Ahamed K.F., Suresh B., and Ramanathan M. Effect of losartan and enalapril on cognitive deficit caused by Goldblatt induced hypertension. Indian J Exp Biol 43 (2005) 241-246
67. Sugawara T., Kinouchi H., Oda M., Shoji H., Omae T., and Mizoi K. Candesartan reduces superoxide production after global cerebral ischemia. Neuroreport 16 (2005) 325-328
68. Tanaka K., Ogawa N., Asanuma M., Kondo Y., and Nomura M. Relationship between cholinergic dysfunction and discrimination learning disabilities in Wistar rats following chronic cerebral hypoperfusion. Brain Res 729 (1996) 55-65
69. Usinger P., Hock F.J., Wiemer G., Gerhards H.J., Henning R., and Urbach H. Hoe 288: indications on the memory enhancing effects of a peptidase inhibitor. Drug Dev Res 14 (1988) 325-334
70. Wang L.M., Han Y.F., and Tang X.C. Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats. Eur J Pharmacol 398 (2000) 65-72
71. Yanpallewar S.U., Rai S., Kumar M., and Acharya S.B. Evaluation of antioxidant and neuroprotective effect of Ocimum sanctum on transient cerebral ischemia and long-term cerebral hypoperfusion. Pharmacol Biochem Behav 79 (2004) 155-164
72. Zhou J., Pavel J., Macova M., Yu Z.X., Imboden H., Ge L., Nishioku T., Dou J., Delgiacco E., and Saavedra J.M. AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats. Stroke 37 (2006) 1271-1276